AceVision

    ESCRS 2023: Presbyopia treatment with microporation therapeutic technology by Ace Vision Group

    By PineDev

    AnnMarie Hipsley, DPT, PhD, Founder and CEO of Ace Vision Group, met with Ophthalmology Times Europe at the 2023 European Society of Cataract and Refractive Surgeons to discuss Ace Vision Group’s microporation therapeutic technology, used to treat presbyopia.

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    The VisioLite® Ophthalmic Laser System & LSM are not yet FDA approved or available in the United States. It is currently in clinical trials only in select areas outside of the United States.